Main Products
Pharmasaga is a clinical drug development company dedicated to development of novel anti-diabetic drugs. PS1, a Pdia4-based small-molecule drug candidate, can treat and reverse diabetes. Pharmasaga has clinical assets and a drug screening platform as described below. Both assets and platform are intended for out-licensing to pharmaceutical companies. (1) PS1 for type 2 diabetes (2) PS1 for type 1 diabetes (3) PS1 is for diabetes of pets. (4) A platform to screen drugs.
Business Interests
Out-Licensing, Clinical Trial Collaboration, Co-Development
Contact Info
Yi-San Lee
COO
+886-908688896
coo@pharmasaga.com